DOW JONES22,327.48+690.70 3.19%
S&P 5002,626.65+85.18 3.35%
NASDAQ7,774.15+271.77 3.62%

BTIG Research Initiates Coverage On Avita Medical with Buy Rating, Announces $10 Price Target

BTIG Research analyst Ryan Zimmerman initiates coverage on Avita Medical (NASDAQ:RCEL) with a Buy rating and a $10 price target.

Benzinga · 03/03/2020 12:50

BTIG Research analyst Ryan Zimmerman initiates coverage on Avita Medical (NASDAQ:RCEL) with a Buy rating and a $10 price target.